Drs Kathy D. Miller and Heather A. Parsons explore the complexities and evolving strategies in managing HER2+ oligometastatic ...
Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma who are candidates for systemic therapy, ...
Researchers have identified biomarkers that can predict disease progression in multiple sclerosis, which could lead to the ...
A study presented at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple ...
News Medical on MSN12h
Study reveals biomarkers that predict disability worsening in multiple sclerosisA pioneering study presented today at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple sclerosis (MS).
In short, these results revealed that both CRLF2 OE and CRLF2-d are correlated with poor prognosis in ALL patients.
At a thrombosis research center, an observational study is underway investigating the impact of numerous biomarkers on ...
More than 66,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.
Molecular Cancer Research publishes articles featuring novel, basic cancer research discoveries that prioritize broad molecular and cellular processes. Areas of emphasis include cell cycle and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback